REQUEST A DEMO
Total
USD $0.00
Search more companies

Medy-Tox Inc. (South Korea)

Main Activities: Chemical Manufacturing | Research and Development in Biotechnology (except Nanobiotechnology)
Full name: Medy-Tox Inc. Profile Updated: February 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Medy-Tox Inc. is engaged in manufacturing of bio pharmaceutical as well as developing and marketing of botulinum toxin related bio products. The company mainly produces Neuronox, which is botulinum toxin type A injection used as remedies for ophthalmic diseases, endocrine diseases, digestive systems, neurological diseases and urology systems, as well as beauty treatment and plastic industries. In addition, Medy-Tox Inc. also provides botulinum toxin test kits and operates a microbial toxin research institute. The company was incorporated in 2000 and is based in Cheongwon County, South Korea.

Headquarters
641-4 Gak-Ri, Ochang-Myeon, Cheongwon-Gun
Chungcheonbuk-Do; Postal Code: 363-883

Contact Details: Purchase the Medy-Tox Inc. report to view the information.

Website: http://www.medytox.com

Basic Information
Total Employees:
Purchase the Medy-Tox Inc. report to view the information.
Outstanding Shares:
Purchase the Medy-Tox Inc. report to view the information.
Registered Capital:
Purchase the Medy-Tox Inc. report to view the information.
Financial Auditors:
Purchase the Medy-Tox Inc. report to view the information.
Incorporation Date:
May 02, 2000
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Auditor
Ownership Details
Purchase this report to view the information.
18.34%
Purchase this report to view the information.
3.03%
Purchase this report to view the information.
0.2%
Purchase this report to view the information.
0.14%
Purchase this report to view the information.
0.01%
Subsidiaries
Mdt International
Company Performance
Financial values in the chart are available after Medy-Tox Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
7.2%
Total operating revenue
7.01%
Operating profit (EBIT)
-58.74%
EBITDA
-50.61%
Net Profit (Loss) for the Period
-67.92%
Total assets
0%
Total equity
8.12%
Operating Profit Margin (ROS)
-11.71%
Net Profit Margin
-18.1%
Return on Equity (ROE)
-5.77%
Quick Ratio
0.11%
Cash Ratio
0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?